STAGE III PRIMARY PERITONEAL CANCER AJCC V7
Clinical trials for STAGE III PRIMARY PERITONEAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PRIMARY PERITONEAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PRIMARY PERITONEAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune-boosting drug shows promise in ovarian cancer fight
Disease control OngoingThis early-phase study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy can help control advanced ovarian, fallopian tube, or primary peritoneal cancer. About 18 people with stage III or IV cancer will receive the combination. The main goal is to me…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Heated chemo during surgery may fight ovarian cancer return
Disease control OngoingThis early-phase trial tests whether giving heated chemotherapy directly into the abdomen during surgery can help prevent cancer from coming back in people with advanced ovarian, fallopian tube, uterine, or peritoneal cancer. About 40 participants will receive the heated chemo du…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Ovarian cancer drug trial aims to unlock DNA secrets before surgery
Knowledge-focused OngoingThis early-phase trial is testing a drug called adavosertib in 38 people with advanced ovarian, fallopian tube, or peritoneal cancer. Participants take the drug for up to 28 days before their scheduled surgery. Researchers will compare tumor DNA before and after treatment to see …
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC